The prognostic significance of programmed cell death protein 1 and its ligand on lymphoma cells and tumor-immune cells in diffuse large B-cell lymphoma, not otherwise specified Cover

.blurhash-client-img { display: none !important; }

The prognostic significance of programmed cell death protein 1 and its ligand on lymphoma cells and tumor-immune cells in diffuse large B-cell lymphoma, not otherwise specified

Radiology and Oncology

Volume 58 (2024): Issue 1 (March 2024)

By: Teja Cas Slak, Simona Miceska, Gorana Gasljevic, Lucka Boltezar and Veronika Kloboves-Prevodnik

Open Access

|Feb 2024

Authors

Teja Cas Slak

Department of Cytopathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Simona Miceska

Department of Cytopathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Gorana Gasljevic

Department of Pathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Faculty of Medicine, University of Maribor, Maribor, Slovenia

Lucka Boltezar

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Veronika Kloboves-Prevodnik

vkloboves@onko-i.si

Department of Cytopathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Faculty of Medicine, University of Maribor, Maribor, Slovenia

DOI: https://doi.org/10.2478/raon-2024-0010 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 99 - 109

Submitted on: Nov 7, 2023

|

Accepted on: Nov 25, 2023

|

Published on: Feb 21, 2024

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

diffuse large B-cell lymphoma,

immunohistochemistry,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2024 Teja Cas Slak, Simona Miceska, Gorana Gasljevic, Lucka Boltezar, Veronika Kloboves-Prevodnik, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous article Volume 58 (2024): Issue 1 (March 2024)Next article